CAS Medical gets two US patents for Fore-Sight cerebral oximeter:
This article was originally published in Clinica
Executive Summary
CAS Medical Systems has gained two US patents for technology used in its noninvasive Fore-Sight cerebral oximeter, which is scheduled for commercial release in late 2006. The product uses the firm's optically-based near infrared spectroscopy technology to monitor absolute levels of oxygen saturation in the brain. This absolute value, displayed on the monitor and updated every few seconds, provides clinicians with an immediate, clear indication of a patient's cerebral oxygen saturation status, said the Branford, Connecticut firm. Cerebral tissue oxygen saturation values are important because lack of oxygen supply to brain tissue is one of the leading causes of brain injuries that occur in many surgical and clinical situations.